Wells Fargo
ANRO icon

Wells Fargo’s Alto Neuroscience ANRO Stock Holding History

Wells Fargo’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Buy
26,303
+25,513
+3,229% +$590K ﹤0.01% 4375
2026
Q1 		$17.8K Buy
790
+25
+3% +$463 ﹤0.01% 5819
2025
Q4 		$13.6K Buy
+765
New +$9.63K ﹤0.01% 5885
2025
Q3 		– Sell
-351
Closed -$772 – 7449
2025
Q2 		$772 Sell
351
-10,886
-97% -$25.9K ﹤0.01% 6335
2025
Q1 		$24.3K Buy
11,237
+248
+2% +$888 ﹤0.01% 5645
2024
Q4 		$46.5K Buy
10,989
+3,139
+40% +$19.6K ﹤0.01% 5510
2024
Q3 		$89.8K Buy
7,850
+4,594
+141% +$56.2K ﹤0.01% 5080
2024
Q2 		$34.8K Buy
3,256
+3,191
+4,909% +$41.5K ﹤0.01% 5422
2024
Q1 		$998 Buy
+65
New +$1.02K ﹤0.01% 6151

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Wells Fargo's ANRO Position: Q2 2026 in Review

Wells Fargo increased its Alto Neuroscience (ANRO) stake by 3,229% in Q2 2026, buying an estimated $590K and bringing the position to 26,303 shares worth $694K. The position accounts for ﹤0.01% of the portfolio, ranked #4375.

Wells Fargo first reported a position in ANRO in Q1 2024 and has held it in 9 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Wells Fargo held 26,303 shares of Alto Neuroscience worth $694K as of Q2 2026.
  • Wells Fargo bought 25,513 Alto Neuroscience shares in Q2 2026, an estimated $590K.
  • Alto Neuroscience made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4375 holding.
  • Wells Fargo first reported a position in Alto Neuroscience in Q1 2024 and has held it in 9 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.